H, G., D, K., E, N., S, K., AC, G., S, G., . . . O, C. (2024). The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients. Blood, 143(11), 983. https://doi.org/10.1182/blood.2023021564
Chicago Style (17th ed.) CitationH, Ghesquières, et al. "The Phase 2 LYSA Study of Prednisone, Vinblastine, Doxorubicin, and Bendamustine for Untreated Hodgkin Lymphoma in Older Patients." Blood 143, no. 11 (2024): 983. https://doi.org/10.1182/blood.2023021564.
MLA (9th ed.) CitationH, Ghesquières, et al. "The Phase 2 LYSA Study of Prednisone, Vinblastine, Doxorubicin, and Bendamustine for Untreated Hodgkin Lymphoma in Older Patients." Blood, vol. 143, no. 11, 2024, p. 983, https://doi.org/10.1182/blood.2023021564.